Transplantation of ACE2- Mesenchymal stem cells improves the outcome of patients with covid-19 pneumonia

Aging and Disease

Volumn 11, Issue 2, 2020, Pages 216-228

  Leng, Zikuan ^a,e   Zhu, Rongjia ^b   Hou, Wei ^c   Feng, Yingmei ^c   Yang, Yanlei ^d   Han, Qin ^b   Shan, Guangliang ^b   Meng, Fanyan ^a   Du, Dongshu ^a   Wang, Shihua ^b   Fan, Junfen ^b   Wang, Wenjing ^c   Deng, Luchan ^b   Shi, Hongbo ^c   Li, Hongjun ^c   Hu, Zhongjie ^c   Zhang, Fengchun ^d   Gao, Jinming ^d   Liu, Hongjian ^e   Li, Xiaoxia ^f   Zhao, Yangyang ^b   Yin, Kan ^f   He, Xijing ^g   Gao, Zhengchao ^g   Wang, Yibin ^g   Yang, Bo ^e   Jin, Ronghua ^c   Stambler, Ilia ^h,i,j   Lim, Lee Wei ^h,i,k   Su, Huanxing ^h,i,l   Moskalev, Alexey ^h,i,m   Cano, Antonio ^h,i,n   Chakrabarti, Sasanka ^o   Min, Kyung Jin ^h,i,p   Ellison Hughes, Georgina ^h,i,q   Caruso, Calogero ^h,i,r   Jin, Kunlin ^h,i,s   Zhao, Robert Chunhua ^a,b,h,i   more..

^a SHANGHAI UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^f QINGDAO UNIVERSITY   (China)

^g THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^h UNESCO   (France)

ⁱ International Society on Aging and Disease (ISOAD)   (United States)

^j TEL AVIV UNIVERSITY   (Israel)

^k UNIVERSITY OF HONG KONG   (Hong Kong)

^l University of Macau   (Macao)

^m INSTITUTE OF BIOLOGY   (Russian Federation)

ⁿ UNIVERSITY OF VALENCIA   (Spain)

^o MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

^p Inha University   (South Korea)

^q KING'S COLLEGE LONDON   (United Kingdom)

^r UNIVERSITY OF PALERMO   (Italy)

^s UNIVERSITY OF NORTH TEXAS   (United States)

more..

Author keywords

ACE2 negative; Cell transplantation; COVID 19; Function recovery; Immunomodulation; Mesenchymal stem cells

Indexed keywords

ALBUMIN; ANGIOTENSIN CONVERTING ENZYME 2; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CXCR3; CREATINE KINASE; CREATINE KINASE ISOENZYME; EPIDERMAL GROWTH FACTOR; FIBRINOGEN; FIBROBLAST GROWTH FACTOR; GALANIN; HEMOGLOBIN; INTERLEUKIN 10; LEUKEMIA INHIBITORY FACTOR; MYOGLOBIN; NERVE GROWTH FACTOR; POTASSIUM; PROCALCITONIN; SCATTER FACTOR; SODIUM; TRANSFORMING GROWTH FACTOR BETA; TROPONIN; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BASOPHIL COUNT; BREATHING RATE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CLINICAL OUTCOME; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; DYSPNEA; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; FEMALE; FEVER; GENE EXPRESSION; GLOMERULUS FILTRATION RATE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IMMUNOMODULATION; LUNG FUNCTION; MALE; MASS CYTOMETRY; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; MONOCYTE COUNT; NATURAL KILLER T CELL; NEUTROPHIL COUNT; OXYGEN CONSUMPTION; REAL TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCING; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS PNEUMONIA; WEAKNESS;

EID: 85082424283     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2020.0228     Document Type: Article

References (27)

1. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E (2020). A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. New England Journal of Medicine.
2. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. SCIENCE CHINA Life Sciences.
3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England).
4. Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature.
5. Kuba K, Imai Y, Rao SA, Gao H, Guo F, Guan B, et al. (2005). A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Medicine, 11:875-879.
6. Ge X-Y, Li J-L, Yang X-L, Chmura AA, Zhu G, Epstein JH, et al. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature, 503:535-+.
7. Hoffmann M, Kleine-Weber H, Krüger N, Müller M, Drosten C, Pöhlmann S (2020). The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv:2020.2001.2031.929042.
8. Glowacka I, Bertram S, Mueller MA, Allen P, Soilleux E, Pfefferle S, et al. (2011). Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response. Journal of Virology, 85:4122-4134.
9. Iwata-Yoshikawa N, Okamura T, Shimizu Y, Hasegawa H, Takeda M, Nagata N (2019). TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection. Journal of Virology, 93.
10. Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathology, 203:631-637.
11. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395:497-506
12. Connick P, Kolappan M, Crawley C, Webber DJ, Patani R, Michell AW, et al. (2012). Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurology, 11:150-156.
13. Wilson JG, Liu KD, Zhuo NJ, Caballero L, McMillan M, Fang XH, et al. (2015). Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respiratory Medicine, 3:24-32.
14. Hashmi S, Ahmed M, Murad MH, Litzow MR, Adams RH, Ball LM, et al. (2016). Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis. Lancet Haematology, 3:E45-E52.
15. Kamen DL, Nietert PJ, Wang H, Duke T, Cloud C, Robinson A, et al. (2018). CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study. Lupus Science & Medicine, 5:A46-A47.
16. Galipeau J, Sensebe L (2018). Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell, 22:824-833.
17. Bernardo ME, Fibbe WE (2013). Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation. Cell Stem Cell, 13:392-402.
18. Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM (2010). A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One, 5:e10088.
19. Li W, Ren G, Huang Y, Su J, Han Y, Li J, et al. (2012). Mesenchymal stem cells: a double-edged sword in regulating immune responses. Cell Death Differ, 19:1505-1513.
20. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA.
21. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England).
22. Chen L, Zhang W, Yue H, Han Q, Chen B, Shi M, et al. (2007). Effects of human mesenchymal stem cells on the differentiation of dendritic cells from CD34(+) cells. Stem Cells and Development, 16:719-731.
23. Liu X, Qu X, Chen Y, Liao L, Cheng K, Shao C, et al. (2012). Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IL-10-Dependent Regulatory Dendritic Cells by SOCS3 Activation. Journal of Immunology, 189:1182-1192.
24. Liu X, Ren S, Ge C, Cheng K, Zenke M, Keating A, et al. (2015). Sca-1(+)Lin(-)CD117(-) Mesenchymal Stem/Stromal Cells Induce the Generation of Novel IRF8-Controlled Regulatory Dendritic Cells through Notch-RBP-J Signaling. Journal of Immunology, 194:4298-4308.
25. Zhang B, Liu R, Shi D, Liu X, Chen Y, Dou X, et al. (2009). Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood, 113:46-57.
26. Sproston NR, Ashworth JJ (2018). Role of C-Reactive Protein at Sites of Inflammation and Infection. Frontiers in Immunology, 9.
27. Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ESG, Kastelein JJP (2010). C-reactive protein is a mediator of cardiovascular disease. European Heart Journal, 31:2087-U1505.